|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 1/22/2019 2:43:24 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 695, FY 2019 Department of Defense Appropriations Act, 2018, provisions relating to funding for NIH, National Diabetes Prevention Program, community health centers, National Health Service Corps, and Teaching Health Center Graduate Medical Education programs
H.R. 1892, Bipartisan Budget Act of 2018, provisions relating to telehealth
FY 2019 Commerce, Justice, Science (CJS), and Related Agencies Appropriations Act, 2019, provisions relating to funding for 2020 census
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, all provisions
H.R. 6199, Restoring Access to Medication and Modernizing Health Savings Accounts Act of 2018, all provisions
H.R. 6082, Overdose Prevention and Patient Safety Act, provisions relating to 42 CFR Part 2/Privacy
S. 2700, Comprehensive Addiction Resources Emergency Act of 2018, provisions relating to workforce training and funding
H.R. 1375, Prescriber Support Act of 2017, all provisions
S. 2456, CARA 2.0 Act of 2018, all provisions
S. 1803, Marijuana Effective Drug Studies (MEDS) Act of 2017, all provisions
H.R. 1318, Preventing Maternal Deaths Act of 2018, all provisions
S. 1112, Maternal Health Accountability Act of 2017, all provisions
21st Century Cures Act implementation
Gun violence prevention and research
Firearm purchase background checks
Pharmacy benefits manager (PBM)
Drug pricing/shortages/prior authorization burdens
Cybersecurity
Electronic health records (EHR) certification
Software as a medical device (SaMD)
Opioid abuse
Medical price transparency
42 CFR Part 2/Substance abuse confidentiality regulations
Administrative burden and simplification
Health Savings Accounts - Prescription requirement for over-the-counter medications
In-office compounding
Telehealth
Family and Medical Leave Act (FMLA)/family relationship
Medically underserved population/persons with intellectual and developmental disabilities
Buprenorphine/hospital inpatients
Dietary Guidelines
National Practitioner Data Bank
National Biodefense strategy
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Office of Natl Drug Control Policy (NDCP), Labor - Dept of (DOL), Health Resources & Services Administration (HRSA), Agriculture - Dept of (USDA), Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
H.R. 7052, No Federal Funds for Public Charge Act of 2018, all provisions
S. 898, Conrad State 30 and Physician Access Reauthorization Act, all provisions
H-1B Visas
Public Charge
Alien minors and unaccompanied alien children
Medical/mental health care of migrant children and pregnant women in federal custody
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Homeland Security - Dept of (DHS), U.S. Citizenship & Immigration Services (USCIS), U.S. Customs & Border Protection
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
Competition in health insurance marketplace
Aetna/CVS merger
Insulin pricing
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act, all provisions
H.R. 930, Lymphedema Treatment Act, all provisions
S. 497, Lymphedema Treatment Act, all provisions
H.R. 6836, CLINICAL TREATMENT Act, all provisions
S. 3592, No More Surprise Medical Bills Act of 2018, all provisions
H.R. 7122, Shared Accountability for Improved Patient Outcomes Act of 2018, all provisions
H.R. 6, SUPPORT for Patients and Communities Act, all provisions
S. 3120, HEAL Act of 2018, all provisions
H.R.3528 - Every Prescription Conveyed Securely Act, all provisions
S. 2460, Every Prescription Conveyed Securely Act, all provisions
H.R. 2687, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions
S. 1169, Medicaid Coverage for Addiction Recovery Expansion Act, all provisions
S. 1016, CONNECT for Health Act of 2017, provisions relating to telehealth
Medicare program: Protecting Patients from Surprise Medical Bills Act
Medicare program: Protecting Access to Medicare Act (PAMA)/physician office labs
Medicare program: Medicare Access and Chip Reauthorization Act (MACRA) implementation
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: MIPS cost measures
Medicare program: MIPS impact on Part B drugs and DME
Medicare program: Physician-Focused Payment Model Technical Advisory Committee (PTAC)
Medicare program: Diabetes Prevention Program/virtual coverage
Medicare program: Evaluation and Management Codes/documentation
Medicare program: Medicare physician fee schedule
Medicare program: Medicare Advantage (MA) and Part D
Medicare program: Quality Payment Program
Medicare program: Shared Savings Program
Medicare program: Health IT burdens
Medicare program: Surprise billing
Medicare program: Graduate Medical Education (GME)
Medicare program: Alternative Payment Models (APMs)
Medicare program: Appropriate Use Criteria
Medicare program: Cybersecurity
Medicare program: Interoperability
Medicare program: Stark/Anti-kickback
Medicare program: Privacy
Medicare program: Regulatory relief
Medicare program: Step therapy
Medicare program: Residents/minor procedures
Medicare program: Prior authorization and utilization management
Medicare program: Medicare for all
Medicare program: Open Payments
Medicare program: PECOS/Medicare Enrollment/Revocations/Revalidations
Medicare program: Pharmacy Benefit Manager (PBM)/drug price transparency
Medicare program: Misvalued codes
Medicare program: List price for drugs
Medicare program: Drug pricing transparency
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), White House Office, Health & Human Services - Dept of (HHS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Office of Natl Drug Control Policy (NDCP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Jennifer |
McLaughlin |
|
|
|
Matthew |
Reid |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Feminine hygiene products tax/HSA/FSA
17. House(s) of Congress and Federal agencies Check if None
Internal Revenue Service (IRS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Jennifer |
Brown |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Tobacco/free trade agreement with Japan
17. House(s) of Congress and Federal agencies Check if None
U.S. Trade Representative (USTR)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Scope of Practice
Veterans Choice Program/community care program transition
Tricare access
Telehealth
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOR |
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |